Auritec Pharmaceuticals
Organisation
People
Sources: reporter.nih.gov
Trials
Early phase 1, Completed, 8 people, 13 Aug 2018
Grants and prizes
Long-acting Injectable Brexpiprazole for Agitation in Alzheimer's Dementia, R44AG102256, US$1m, 17 Sept 2026
Sources: reporter.nih.gov